委外研发机构的市场规模、份额、成长分析，按应用、按最终用户、按地区 - 行业预测，2024-2031

2022年全球合约药物委外研发机构市场规模约为680亿美元，高于2023年的751亿美元，在预测期间（2024-2031）至2031年的复合年增长率为9.5%，预计将达到1552亿美元。

由于临床试验的复杂性不断增加以及对外包研究服务的需求不断增加，全球合约委外研发机构（CRO）市场正在稳步增长。 CRO 提供广泛的服务，包括临床试验管理、资料管理、法规事务和化验服务。 CRO 协助製药、生技和医疗设备公司简化研发流程、降低成本并加快新产品的上市时间。市场高度分散，参与者众多，从大型全方位服务 CRO 到小型利基公司。技术进步，特别是资料分析和数位健康解决方案，正在对市场动态产生重大影响。对个人化医疗的日益重视和慢性病的盛行率增加也促进了市场的扩张。此外，主要市场参与者之间的策略联盟和併购正在塑造竞争格​​局。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 市场生态系统
• 价值链分析
• 价格分析
• 案例研究分析
• 技术分析
• 监管分析
• 创新矩阵
• 重点投资分析
• 关键成功因素
• 竞争程度

药品委外研发机构市场：按类型

• 市场概况
• 临床研究服务
  • 按阶段
  • 第三阶段
  • 第二阶段
  • 第一阶段
  • 第四阶段
  • 依研究设计（III期/IV期）
  • 干涉
  • 真实世界证据 (RWE)
• 初期开发服务
  • 化学、製造和控制服务
  • 临床前服务
  • 药物动力学/动态服务
  • 毒理学测试服务
  • 其他临床前服务
  • 发现研究
• 化验服务
  • 分析测试服务
  • 物理表征服务
  • 原料检测服务
  • 大量发布测试服务
  • 稳定性测试服务
  • 其他分析测试服务
  • 生物分析测试服务
• 咨询服务
• 资料管理服务

药物委外研发机构市场：依治疗领域

• 市场概况
• 肿瘤学
  • 乳癌
  • 肺癌
  • 大肠直肠癌
  • 摄护腺癌
  • 其他癌症
• 感染疾病
• CVS 故障
• 神经病学
• 疫苗
• 代谢疾病/内分泌学
• 免疫疾病
• 精神病学
• 呼吸系统疾病
• 皮肤科
• 眼科
• 消化系统疾病
• 泌尿系统和女性健康
• 血液学
• 其他治疗领域

药品委外研发机构市场：依最终用户分类

• 市场概况
• 製药和生物製药公司
• 医疗设备公司
• 学术机构

药品委外研发机构市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要参与者采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• IQVIA
• Laboratory Corporation of America Holdings（Labcorp）
• PPD Inc.（a part of Thermo Fisher Scientific, Inc.）
• Syneos Health Inc.
• WuXi AppTec Co., Ltd.
• Charles River Laboratories International, Inc.
• Parexel International Corporation
• Pharmaron Beijing Co., Ltd.
• ICON PLC
• Medpace Holdings, Inc.
• SGS SA
• Frontage Holdings Corporation
• PSI CRO AG
• BioAgile Therapeutics Pvt. Ltd.
• Firma Clinical Research, LLC
• AccuLab Life Sciences
• Novotech Health Holdings
• KCR（formerly Kiecana Clinical Research）
• Linical Co., Ltd.
• Advanced Clinical
• Azelix LLC
• Clinical Trial Service BV
• Pepgra Healthcare Pvt. Ltd.
• Worldwide Clinical Trials Holdings Inc.
• CTI Clinical Trial and Consulting Services, Inc

Global Contract Research Organization Market size was valued at around 68 billion in 2022 and is expected to rise from USD 75.1 billion in 2023 to reach a value of USD 155.2 billion by 2031, at a CAGR of 9.5% over the forecast period (2024-2031).

The global Contract Research Organization (CRO) market has experienced robust growth due to the increasing complexity of clinical trials and the rising demand for outsourced research services. CROs provide a range of services including clinical trial management, data management, regulatory affairs, and laboratory services. They are instrumental in helping pharmaceutical, biotechnology, and medical device companies streamline their R&D processes, reduce costs, and accelerate time-to-market for new products. The market is characterized by a high degree of fragmentation, with numerous players ranging from large, full-service CROs to smaller niche firms. Technological advancements, particularly in data analytics and digital health solutions, are significantly impacting the market dynamics. The growing emphasis on personalized medicine and the increasing prevalence of chronic diseases are also contributing to the market's expansion. Additionally, strategic collaborations and mergers and acquisitions among key market players are shaping the competitive landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contract Research Organization Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contract Research Organization Market Segmental Analysis

Global Contract Research Organization Market is segmented by Type, Therapeutic Area, End User, and region. Based on Product, the market is segmented into Clinical Research Services ( Phase (Phase III, Phase II, Phase I, Phase IV), By Study Design (For Phase III & IV) (Interventional, Real World Evidence (RWE)), Early phase development Services (Chemistry, Manufacturing and Controls Services, Preclinical Services (Pharmacokinetics/ Pharmacodynamics Services, Toxicology Testing Services, Other Preclinical Services), Discovery Studies), Laboratory Services (Analytical Testing Services (Physical Characterization Services, Raw Material Testing Services, Batch Release Testing Services, Stability Testing Services, Other Analytical Testing Services), Bioanalytical Testing Services), Consulting Services, and Data Management Services. Based on Therapeutic Area, the market is segmented into Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Cancer), Infectious Diseases, CVS Disorders, Neurology, Vaccines, Metabolic Disorders/Endocrinology, Immunological Disorders, Psychiatry, Respiratory Disorders, Dermatology, Ophthalmology, Gastrointestinal Diseases, Genitourinary & Women's Health, Hematology, and Other Therapeutic Areas. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Contract Research Organization Market

One major driver of the global CRO market is the rising need for cost-effective and efficient R&D solutions. Pharmaceutical and biotechnology companies are increasingly outsourcing clinical trials and other research activities to CROs to manage costs and mitigate risks associated with drug development. CROs offer specialized expertise and resources that can help streamline the drug development process, reduce operational costs, and improve the overall efficiency of clinical trials. This trend is particularly prevalent among smaller companies and startups that lack the extensive infrastructure required for large-scale clinical research. By leveraging CROs, these organizations can focus on their core competencies while benefiting from the CROs' experience, advanced technologies, and global reach, which ultimately supports faster and more cost-effective product development.

Restraints in the Global Contract Research Organization Market

A significant restraint in the global CRO market is the regulatory complexity and variability across different regions. CROs must navigate diverse regulatory requirements and standards set by various health authorities worldwide, which can be challenging and time-consuming. The differences in regulations, clinical trial procedures, and data privacy laws between countries can lead to delays, increased costs, and potential compliance issues. This regulatory burden can affect the efficiency of clinical trials and pose challenges for CROs in managing multi-regional studies. Additionally, discrepancies in regulatory guidelines can impact the standardization of trial protocols and data reporting, complicating the process for both CROs and their clients.

Market Trends of the Global Contract Research Organization Market

A prominent trend in the global CRO market is the growing integration of advanced technologies, such as artificial intelligence (AI) and machine learning, into clinical trials. These technologies are revolutionizing the way clinical research is conducted by enhancing data analysis, improving patient recruitment, and optimizing trial designs. AI algorithms can analyze vast amounts of data to identify potential drug candidates, predict patient responses, and uncover new insights that can accelerate the drug development process. Additionally, machine learning tools are being used to streamline data management and enhance decision-making processes. This technological advancement is helping CROs deliver more accurate and efficient research outcomes, thereby increasing their value proposition to pharmaceutical and biotechnology companies. The adoption of these technologies is expected to continue growing, further driving innovation and efficiency in the CRO market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Ecosystem of the Market
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis
• Technology Analysis
• Regulatory Analysis
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Contract Research Organization Market by Type

• Market Overview
• Clinical Research Services
  • By Phase
  • Phase III
  • Phase II
  • Phase I
  • Phase IV
  • By Study Design (For Phase III & IV)
  • Interventional
  • Real World Evidence (RWE)
• Early phase development Services
  • Chemistry, Manufacturing and Controls Services
  • Preclinical Services
  • Pharmacokinetics/ Pharmacodynamics Services
  • Toxicology Testing Services
  • Other Preclinical Services
  • Discovery Studies
• Laboratory Services
  • Analytical Testing Services
  • Physical Characterization Services
  • Raw Material Testing Services
  • Batch Release Testing Services
  • Stability Testing Services
  • Other Analytical Testing Services
  • Bioanalytical Testing Services
• Consulting Services
• Data Management Services

Contract Research Organization Market by Therapeutic Area

• Market Overview
• Oncology
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Other Cancer
• Infectious Diseases
• CVS Disorders
• Neurology
• Vaccines
• Metabolic Disorders/Endocrinology
• Immunological Disorders
• Psychiatry
• Respiratory Disorders
• Dermatology
• Ophthalmology
• Gastrointestinal Diseases
• Genitourinary & Women's Health
• Hematology
• Other Therapeutic Areas

Contract Research Organization Market by End User

• Market Overview
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Contract Research Organization Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• IQVIA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (Labcorp)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD Inc. (a part of Thermo Fisher Scientific, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaron Beijing Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSI CRO AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgile Therapeutics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Firma Clinical Research, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AccuLab Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novotech Health Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCR (formerly Kiecana Clinical Research)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Clinical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azelix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinical Trial Service BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pepgra Healthcare Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTI Clinical Trial and Consulting Services, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments